Drug Shortage Report for STAXYN
Report ID | 62147 |
Drug Identification Number | 02372436 |
Brand name | STAXYN |
Common or Proper name | Vardenafil Tablets |
Company Name | BAYER INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VARDENAFIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 4's |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-11-15 |
Actual start date | 2018-11-13 |
Estimated end date | Unknown |
Actual end date | 2022-08-31 |
Shortage status | Resolved |
Updated date | 2022-09-29 |
Company comments | Dormant DIN |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.